10416007

Source:http://linkedlifedata.com/resource/pubmed/id/10416007

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:10416007	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:10416007	lifeskim:mentions	umls-concept:C0013216	lld:lifeskim
pubmed-article:10416007	lifeskim:mentions	umls-concept:C0242456	lld:lifeskim
pubmed-article:10416007	lifeskim:mentions	umls-concept:C0220647	lld:lifeskim
pubmed-article:10416007	lifeskim:mentions	umls-concept:C0449695	lld:lifeskim
pubmed-article:10416007	lifeskim:mentions	umls-concept:C0522510	lld:lifeskim
pubmed-article:10416007	pubmed:issue	5	lld:pubmed
pubmed-article:10416007	pubmed:dateCreated	1999-9-2	lld:pubmed
pubmed-article:10416007	pubmed:abstractText	Unknown primary tumors are highly malignant diseases which portend a dire prognosis. We designed a prospective high dose-intensity policy with the aim of improving the results obtained with conventional chemotherapy.	lld:pubmed
pubmed-article:10416007	pubmed:language	eng	lld:pubmed
pubmed-article:10416007	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:10416007	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:10416007	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:10416007	pubmed:month	May	lld:pubmed
pubmed-article:10416007	pubmed:issn	0923-7534	lld:pubmed
pubmed-article:10416007	pubmed:author	pubmed-author:PujolHH	lld:pubmed
pubmed-article:10416007	pubmed:author	pubmed-author:FabbriGG	lld:pubmed
pubmed-article:10416007	pubmed:author	pubmed-author:CupissolDD	lld:pubmed
pubmed-article:10416007	pubmed:author	pubmed-author:CulineSS	lld:pubmed
pubmed-article:10416007	pubmed:author	pubmed-author:YchouMM	lld:pubmed
pubmed-article:10416007	pubmed:author	pubmed-author:RomieuGG	lld:pubmed
pubmed-article:10416007	pubmed:issnType	Print	lld:pubmed
pubmed-article:10416007	pubmed:volume	10	lld:pubmed
pubmed-article:10416007	pubmed:owner	NLM	lld:pubmed
pubmed-article:10416007	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:10416007	pubmed:pagination	569-75	lld:pubmed
pubmed-article:10416007	pubmed:dateRevised	2006-4-24	lld:pubmed
pubmed-article:10416007	pubmed:meshHeading	pubmed-meshheading:10416007...	lld:pubmed
pubmed-article:10416007	pubmed:meshHeading	pubmed-meshheading:10416007...	lld:pubmed
pubmed-article:10416007	pubmed:meshHeading	pubmed-meshheading:10416007...	lld:pubmed
pubmed-article:10416007	pubmed:meshHeading	pubmed-meshheading:10416007...	lld:pubmed
pubmed-article:10416007	pubmed:meshHeading	pubmed-meshheading:10416007...	lld:pubmed
pubmed-article:10416007	pubmed:meshHeading	pubmed-meshheading:10416007...	lld:pubmed
pubmed-article:10416007	pubmed:meshHeading	pubmed-meshheading:10416007...	lld:pubmed
pubmed-article:10416007	pubmed:meshHeading	pubmed-meshheading:10416007...	lld:pubmed
pubmed-article:10416007	pubmed:meshHeading	pubmed-meshheading:10416007...	lld:pubmed
pubmed-article:10416007	pubmed:meshHeading	pubmed-meshheading:10416007...	lld:pubmed
pubmed-article:10416007	pubmed:meshHeading	pubmed-meshheading:10416007...	lld:pubmed
pubmed-article:10416007	pubmed:year	1999	lld:pubmed
pubmed-article:10416007	pubmed:articleTitle	Chemotherapy in carcinomas of unknown primary site: a high-dose intensity policy.	lld:pubmed
pubmed-article:10416007	pubmed:affiliation	Centre Régional de Lutte contre le Cancer Val d'Aurelle, Montpellier, France. StCuline@valdorel.fnclcc.fr	lld:pubmed
pubmed-article:10416007	pubmed:publicationType	Journal Article	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:10416007	lld:pubmed